Loading
Heart Failure / Elastic band-based progressive resistance training (EB-PRT) · Interventional Study
ClinicalTrials.gov · September 4, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a registry record for an active pilot randomised controlled trial evaluating elastic band-based progressive resistance training for sarcopenia in heart failure patients. No results are reported in this record; the study is currently recruiting or recently closed to recruitment, and outcomes will be measured at 14 and 26 weeks. The registry documents the planned protocol and primary outcome measures but does not provide evidence of effectiveness.
Interventional, Randomized, Parallel, Single masking, Prevention purpose. Heart Failure; age from 50 Years. Intervention: EB-PRT. Compared with: Usual care — No Intervention. n = 62. 1 site: Hong Kong.
This is a registry record for an active pilot randomised controlled trial evaluating elastic band-based progressive resistance training for sarcopenia in heart failure patients. No results are reported in this record; the study is currently recruiting or recently closed to recruitment, and outcomes will be measured at 14 and 26 weeks. The registry documents the planned protocol and primary outcome measures but does not provide evidence of effectiveness.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should await publication of results from this pilot trial before considering adoption of elastic band-based progressive resistance training as a standard intervention for sarcopenia in heart failure. The study will provide preliminary evidence on feasibility and effect sizes, which may inform future larger trials.
This is a registry record for an active, ongoing pilot RCT with no results posted; the study is designed to evaluate preliminary effects of resistance training on sarcopenia in heart failure patients.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians should await publication of results from this pilot trial before considering adoption of elastic band-based progressive resistance training as a standard intervention for sarcopenia in heart failure. The study will provide preliminary evidence on feasibility and effect sizes, which may inform future larger trials.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06161402). This is a study registration, not published results. Lead sponsor: The University of Hong Kong. Recruitment status: ACTIVE_NOT_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 62 participants (ESTIMATED). Conditions: Heart Failure. Interventions: BEHAVIORAL: Elastic band-based progressive resistance training (EB-PRT). Primary outcome measures: Appendicular skeletal muscular index (ASMI) , Changes from baseline to 14 weeks (1st post-test) and 26 weeks (2nd post-test).; Handgrip strength , Changes from baseline to 14 weeks (1st post-test) and 26 weeks (2nd post-test).; Physical function , Changes from baseline to 14 weeks (1st post-test) and 26 weeks (2nd post-test).. Brief summary: Heart failure (HF) is a complicated clinical syndrome caused by structural and/or functional cardiac abnormalities that result in ineffective myocardial pumping. HF management has placed more emphasis on improving the prognostic factors which determine these poor clinical outcomes. More recently, the prognostic role of sarcopenia in HF has received particular attention. Defined as progressive and generalized decline in skeletal muscle mass, strength and physical performance due to aging, sarcopenia is definitely a common comorbid of HF which follows an age-specific disease epidemiology. Given muscle disuse is the most preventable and reversible factor of sarcopenia, more evidence points to the therapeutic value of resistance training (RT) for this debilitating condition. Nevertheless, the therapeutic effects of RT on improving sarcopenia and thereby the disease prognosis among HF patients is yet to be evaluated. Therefore, the sequential mixed method study including a pilot RCT will be conducted to evaluate the preliminary effect of a 14-week elastic band-progressive resistance training (EB-PRT) and a subsequent qualitative study to explore the subjects' engagement experience. The outcomes cover the whole set of defining characteristics including muscle mass, muscle strength and functional performance and the clinical outcomes which reflect HF disease severity and patient-reported HRQL.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.